Brian Miller, M.D., M.B.A., M.P.H. is an Internal Medicine Resident at Georgetown University and an Adjunct Assistant Professor at the UNC Kenan-Flagler School of Business, where he teaches insurance design in the MBA program. Dr. Miller is a member of the AMA’s CPT Advisory Committee as a technical advisor for clinical preventive services, representing 5,000 public health physicians. He currently serves as an expert consultant on health insurance for the FTC’s Bureau of Consumer Protection.

Dr. Miller previously served as a Medical Officer in the Office of New Drugs at the Center for Drug Evaluation and Research at the FDA, where he was one of two physician reviewers who completed the pre-market review of valbenazine, a first-in-class, breakthrough new molecular entity indicated for tardive dyskinesia. He completed a Public Health Residency at Johns Hopkins University, comprised of a federal regulatory rotational program with postings at CMS, FTC, FCC, and FDA, while practicing ambulatory medicine at Johns Hopkins Community Physicians.

Dr. Miller has experience with healthcare merger review, healthcare finance innovation, and pharmaceutical product review. He previously served as a Special Advisor to the FTC’s Office of Policy Planning and concurrently as an in-house physician expert for the Bureau of Competition, assisting in merger review & enforcement in health systems, PBMs, and pharmaceuticals, including the FTC’s successful action blocking the $7 billion Advocate – NorthShore merger. Prior to the FTC, Dr. Miller was a Fellow at the CMS Innovation Center, where he co-managed the ACO Investment Model, a $114 million project focused on ACOs in rural areas.

Dr. Miller received his M.P.H. from Johns Hopkins, his M.B.A. from UNC, and his M.D. from Northwestern University. He is board-certified & licensed to practice medicine in DC.